Home › Studies › PRJNA701961
PRJNA701961 SRP306476

Donor and recipient gut metagenomes in FMT for CDI, Calgary

Donor and recipient stool metagenomes from a fecal microbiota transplantation study

109 stool metagenome samples from FMT donors and recipients in Calgary, Canada, including individuals with gastrointestinal infection/diarrhoea or ulcerative colitis; case-control design studying fecal microbiota transplantation. machine-written summary

109 samples · 109 runs · CA · Age unknown · 2021 · 9.51 Gbp / sample

Sources
✓Sequence archive 1,271○Abstract / description○Full text✓Supplementary tables 39–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive1,271 sample values (antibiotic exposure, collection date, country, health condition, health condition detail, intervention, intervention detail, latitude)
○ Abstract / descriptionread; no usable statement
○ Full textread; no usable statement or table · PMC10108530, PMC11081829, PMC11211831, PMC12180181, PMC13213781, PMC9621045
✓ Supplementary tables39 sample values (timepoint)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention · arms resolved

EFaecal microbiota transplantation: 10 people · 70 samplesFMT 10 people · 70 samplesControl / pre-intervention baseline (sample level only): 2 people · 39 samplesno intervention 2 people · 39 samples
exposed vs. not exposed (observational)

Faecal microbiota transplantation design observational_with_procedure · population gi_infection_or_diarrhoea · FMT for recurrent C. difficile infection from healthy donors

“ten FMT recipients (five recipients per donor)” — bioproject.description (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 sampling locations · 1 country
Age
unknown109
Condition
gi_infection_or_diarrhoea51
healthy_control29
ulcerative_colitis19
Country
CA109
Body site
primary109
Collected 2014–2017
2014: 5 samples2015: 46 samples2016: 56 samples2017: 2 samples20142017
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 65 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 43 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)this project, 30–100 Gbp: 1 samplesall projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 9.51 Gbp per sample0130Gbp
! Self-contradictory metadata

health condition: sample names and supplementary table disagree for 10 samples (e.g. healthy_control vs ibd_or_gi_disease) — withheld.

The sources disagree on 10 samples. Where two incompatible values exist for one sample (or one person's samples disagree on sex), neither value is published: the field is left empty here, in the sample sheet and in the downloads. Both sides, with their sources, are in gut_metadata_contradictions.parquet of the data package (what counts as a contradiction).

Contradicted values (10)
samplefieldvalueother valuehandling
SAMN17918343health conditionhealthy_control (sample names)ibd_or_gi_disease (supplementary table)withheld: neither value published
SAMN17918344health conditionhealthy_control (sample names)gi_infection_or_diarrhoea (supplementary table)withheld: neither value published
SAMN17918345health conditionhealthy_control (sample names)gi_infection_or_diarrhoea (supplementary table)withheld: neither value published
SAMN17918349health conditionhealthy_control (sample names)ibd_or_gi_disease (supplementary table)withheld: neither value published
SAMN17918350health conditionhealthy_control (sample names)gi_infection_or_diarrhoea (supplementary table)withheld: neither value published
SAMN17918366health conditionhealthy_control (sample names)ibd_or_gi_disease (supplementary table)withheld: neither value published
SAMN17918367health conditionhealthy_control (sample names)gi_infection_or_diarrhoea (supplementary table)withheld: neither value published
SAMN17918370health conditionhealthy_control (sample names)gi_infection_or_diarrhoea (supplementary table)withheld: neither value published
SAMN17918372health conditionhealthy_control (sample names)gi_infection_or_diarrhoea (supplementary table)withheld: neither value published
SAMN17918373health conditionhealthy_control (sample names)gi_infection_or_diarrhoea (supplementary table)withheld: neither value published
Sampling design and relatedness

longitudinalFMT donor → recipient

12 of 12 people sampled more than once (109 samples; median 8, up to 24 per person) · follow-up median 11 mo (max 21 mo) · median interval between samples 22 d (time from collection dates). Schedule stated by the source: “Recipients: baseline pre-FMT sample, then 5-9 post-FMT samples over up to 336 days; Donors: 24 (A) and 15 (B) samples over 636/532 days” (time origin: transplant); stated follow-up 11 mo.

DADA: day 0DA: day 3DA: day 4DA: day 5DA: day 41DA: day 48DA: day 49DA: day 301DA: day 339DA: day 346DA: day 354DA: day 360DA: day 391DA: day 446DA: day 452DA: day 473DA: day 476DA: day 516DA: day 542DA: day 553DA: day 614DA: day 622DA: day 627DA: day 636DA_R01DA_R01: day 0DA_R01: day 11DA_R01: day 18DA_R01: day 38DA_R01: day 180DA_R01: day 346DA_R02DA_R02: day 0DA_R02: day 18DA_R02: day 24DA_R02: day 45DA_R02: day 108DA_R02: day 180DA_R02: day 353DA_R03DA_R03: day 0DA_R03: day 2DA_R03: day 3DA_R03: day 25DA_R03: day 33DA_R03: day 47DA_R03: day 103DA_R03: day 187DA_R04DA_R04: day 0DA_R04: day 9DA_R04: day 18DA_R04: day 34DA_R04: day 41DA_R04: day 95DA_R04: day 179DA_R04: day 347DA_R05DA_R05: day 0DA_R05: day 56DA_R05: day 111DA_R05: day 195DA_R05: day 363DBDB: day 0DB: day 36DB: day 50DB: day 51DB: day 120DB: day 121DB: day 164DB: day 172DB: day 189DB: day 196DB: day 240DB: day 247DB: day 297DB: day 503DB: day 532DB_R01DB_R01: day 0DB_R01: day 20DB_R01: day 40DB_R01: day 62DB_R01: day 117DB_R01: day 201DB_R01: day 369DB_R02DB_R02: day 0DB_R02: day 67DB_R02: day 75DB_R02: day 152DB_R02: day 243DB_R02: day 404DB_R03DB_R03: day 0DB_R03: day 4DB_R03: day 13DB_R03: day 33DB_R03: day 89DB_R03: day 169DB_R03: day 221DB_R03: day 299DB_R04DB_R04: day 0DB_R04: day 9DB_R04: day 17DB_R04: day 38DB_R04: day 79DB_R04: day 91DB_R04: day 181DB_R04: day 227DB_R04: day 344DB_R05DB_R05: day 0DB_R05: day 6DB_R05: day 29DB_R05: day 90DB_R05: day 169DB_R05: day 3370 d5 mo10 mo16 mo21 mo

Each row is one person (12 shown); dots are samples at days since that person's first sample.

FMT: 2 donors (DA, DB) sampled longitudinally, each linked to 5 recipients (10 donor->recipient pairs).

donor: DA, DA_R01, DA_R02, DA_R03, DA_R04, DA_R05DA donor of DA_R01DA donor of DA_R02DA donor of DA_R03DA donor of DA_R04DA donor of DA_R05DA — donor · 24 samplesDDADA_R01 — recipient · 6 samplesRDA_R01DA_R02 — recipient · 7 samplesRDA_R02DA_R03 — recipient · 8 samplesRDA_R03DA_R04 — recipient · 8 samplesRDA_R04DA_R05 — recipient · 5 samplesRDA_R05
donor: DB, DB_R01, DB_R02, DB_R03, DB_R04, DB_R05DB donor of DB_R01DB donor of DB_R02DB donor of DB_R03DB donor of DB_R04DB donor of DB_R05DB — donor · 15 samplesDDBDB_R01 — recipient · 7 samplesRDB_R01DB_R02 — recipient · 6 samplesRDB_R02DB_R03 — recipient · 8 samplesRDB_R03DB_R04 — recipient · 9 samplesRDB_R04DB_R05 — recipient · 6 samplesRDB_R05

donorrecipient · circles are people (pale = no sequenced sample), arrows run donor → recipient and parent → child, curved lines join twins, partners and siblings, squares are shared settings or families without recorded roles. Shown: 2 linked groups from explicit relations. 12 people in the project overall.

How longitudinal and relatedness information is derived

Community composition
Bacteroides 7.6%Blautia_A 7.0%Roseburia 5.6%Akkermansia 4.6%Anaerostipes 3.8%Fusicatenibacter 3.6%Faecalibacterium 3.2%Ruminococcoides 3.1%Eubacterium_R 2.8%Escherichia 2.5%Gemmiger 2.3%Faecalibacillus 2.2%not assigned to a genus 3.3%other genera 48.5%

Genera, mean relative abundance over 100 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category0 0%
country109 100%109
health_condition99 91%99
subject_id109 100%109
collection_date109 100%109
detailed_location109 100%
health_condition_detail109 100%109
intervention109 100%109
latitude109 100%109
location_locality109 100%109
location_region109 100%109
longitude109 100%109
timepoint_label109 100%7039
intervention_detail70 64%70
antibiotic_exposure51 47%51
Papers (7)
  • Metabolic independence drives gut microbial colonization and resilience in health and disease. 2023 PMID 37069665 PMC10108530 own_data
  • Adaptive ecological processes and metabolic independence drive microbial colonization and resilience in the human gut 2021 own_data
  • Functional profile of host microbiome indicates Clostridioides difficile infection. 2022 PMID 36289064 PMC9621045 unsure
  • A metagenomics pipeline reveals insertion sequence-driven evolution of the microbiota. 2024 PMID 38565143 PMC11081829 unsure
  • Floria: fast and accurate strain haplotyping in metagenomes. 2024 PMID 38940183 PMC11211831 unsure
2 more
  • Engrafting gut bacteriophages have potential to modulate microbial metabolism in fecal microbiota transplantation. 2025 PMID 40542451 PMC12180181
  • Cohesive modules of engraftment in fecal microbiota transplantation. 2026 PMID 42211136 PMC13213781
Details
Archive description

Stool sample metagenomes from two healthy FMT donors and ten FMT recipients (five recipients per donor). All recipients had chronic, recurrent Clostridium difficile infection (CDI) and received vancomycin for a minimum of ten days prior to FMT. Recipients did not take any antibiotics on the day of transplant, or for the remaining duration of the sampling period.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of age unknown by sonnet_x2 with confidence 0.75. Assay shotgun_dna.

  • host run.host_tax_id · “9606”
  • body site study.title · “stool metagenomes”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN17918377antibiotic_exposurenoR10.70sample.name_rule:sample_aliasDA_R01_CDI_P_02_POST
SAMN17918336collection_date2014-12-12R10.90biosample.attribute:collection_date2014-12-12
SAMN17918336countryCAR10.90sample.attr.geo_loc_nameCanada: Calgary
SAMN17918336health_conditionhealthy_controlR10.70sample.name_rule:sample_aliasDA_D_01
SAMN17918375health_conditiongi_infection_or_diarrhoeaR10.90biosample_attrClostridium difficile infection
SAMN17918336health_condition_detailDR10.70sample.name_rule:sample_aliasDA_D_01
SAMN17918375health_condition_detailClostridium difficile infectionR10.90sample.attr.host_diseaseClostridium difficile infection
SAMN17918336interventionno_interventionR10.70sample.name_rule:sample_aliasDA_D_01
SAMN17918375interventionfmtR10.90biosample.attribute:FMT_methodFMT_method: pill
SAMN17918375intervention_detailFMT administered via pillR10.90biosample.attribute:FMT_methodFMT_method: pill
SAMN17918336latitude51.0447R10.90biosample.attribute:lat_lon51.0447 N 114.0719 W
SAMN17918336location_localityCalgaryR10.85biosample.attribute:geo_loc_nameCanada: Calgary
SAMN17918336location_regionAlbertaR10.60biosample.attribute:lat_lon51.0447 N 114.0719 W
SAMN17918336longitude-114.0719R10.90biosample.attribute:lat_lon51.0447 N 114.0719 W
SAMN17918336subject_idDAR10.70sample.name_rule:sample_aliasDA_D_01
SAMN17918375timepoint_labelpre-FMTR10.70sample.name_rule:sample_aliasDA_R01_CDI_P_08_PRE
SAMN17918336timepoint_labelday 0R20.85paper.supp.13059_2023_2924_MOESM1_ESM.xlsx[a) Donor samples!DaysRelative to First Sampling Date]DA_D_01: 0
Sequencing

109 runs over 109 samples · mean 10.50 Gbp per run (median 9.51 Gbp, total 1,143.99 Gbp; 109 runs with a base count) · layout PAIRED 109 · platform ILLUMINA 109 · models NextSeq 500 (109) · 92% of runs with a Sandpiper profile · first public 2021-03-05

Authors (38)

Watson AR first · Füssel J · Veseli I · DeLongchamp JZ · Silva M · Trigodet F · Lolans K · Shaiber A · Fogarty E · Runde JM · Quince C · Yu MK · Söylev A · Morrison HG · Lee STM · Kao D · Rubin DT · Jabri B · Louie T · Eren AM last · Shaw J first · Gounot JS · Chen H · Nagarajan N · Yu YW last · Ji S first · Ahmad F · Peng B · Yang Y · Su M · Zhao X · Vatanen T last · Rashidi A first · Minot SS · Lee SJ · Hill GR · Podlesny D last · Lee ST

Downloads

PRJNA701961.csv.gz (4.6 KB) · parquet (76.7 KB) — all 109 samples, every field with route and confidence · PRJNA701961_determinations.csv.gz (11.3 KB) — 1,310 evidence rows

Samples (109 · every field this project has values for · hover a cell for its source)
Loading the sample table…